Abstract
This group of pancreatic neoplasms is characterized by a predominant neuroendocrine differentiation. Over the years, the terminology and classification of endocrine neoplasia arising in the pancreas has undergone multiple changes. The most recent alterations were introduced in 2010 by the WHO classification of tumors of the digestive system, 6 years after the WHO classification of tumors of endocrine organs had been published. The rationale for the change in classification and the defining criteria of the various categories are discussed in this chapter. A detailed description of the wide range of microscopic appearances that can be exhibited by pancreatic neuroendocrine neoplasia is provided, and the differential diagnostic considerations thereof are discussed. Separate chapter sections are dedicated to the application of the current staging systems and the indications for the use of immunohistochemistry. Information regarding clinical aspects of functioning and nonfunctioning endocrine tumors, together with the genetic syndromes that include pancreatic neuroendocrine tumors, is also provided.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Klimstra DS, Arnold R, Capela C, Hruban RH, Klöppel G, Komminoth P, et al. Neuroendocrine neoplasms of the pancreas. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. WHO classification of tumours of the digestive system, World Health Organization classification of tumours. Lyon: International Agency for Research on Cancer (IARC); 2010. p. 322–6, chapter 12.
Heitz PU, Komminoth P, Perren A, Klimstra DS, Dayal Y, Bordi C, et al. Tumours of the endocrine pancreas. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C, editors. Pathology and genetics. Tumours of endocrine organs, World Health Organization classification of tumours. Lyon: International Agency for Research on Cancer (IARC); 2004. p. 176–208, chapter 4.
Anlauf M, Bauersfeld J, Raffel A, Koch CA, Henopp T, Alkatout I, et al. Insulinomatosis. A multicentric insulinoma disease that frequently causes early recurrent hyperinsulinemic hypoglycemia. Am J Surg Pathol. 2009;33:339–46.
Verbeke CS. Endocrine tumours of the pancreas. Histopathology. 2010;56:669–82. doi:10.1111/j.1365-2559.2010.03490.x.
Yachida S, Vakiani E, White CM, Zhong Y, Saunders T, Morgan R, et al. Small and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors. Am J Surg Pathol. 2012;36:173–84.
Klöppel G, Rindi G, Perren A, Komminoth P, Klimstra DS. The ENETS and AJCC/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: a statement. Virchows Arch. 2010;456:595–7.
Couvelard A. Neuroendocrine tumours of the pancreas: recent developments in staging and grading. Diagn Pathol. 2012;18:1–7.
Klöppel G, Couvelard A, Perren A, Komminoth P, McNicol A-M, Nilsson O, et al. ENETS consensus guidelines for the standards of care in neuroendocrine tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification. Neuroendocrinology. 2009;90:162–6.
Chan ES, Alexander J, Swanson PE, Jain D, Yeh MM. PDX-1, CDX-2, TTF-1, and CK7: a reliable immunohistochemical panel for pancreatic neuroendocrine neoplasms. Am J Surg Pathol. 2012;36:737–43.
Rindi G, Klöppel G, Ahlman H, Caplin M, Couvelard A, de Herder WW, et al. TNM staging of foregut (neuro)endocrine tumours: a consensus proposal including a grading system. Virchows Arch. 2006;449:395–401.
Sobin LH, Gospodarowicz MK, Wittekind C, editors. UICC: TNM classification of malignant tumours. 7th ed. Oxford: Wiley-Blackwell; 2009.
Takahashi T, Hatakeyama S, Machida T. Ductal adenocarcinoma of the pancreas with psammomatous calcification: report of a case with immunohistochemical study for bone morphogenetic protein. Pathol Int. 2011;61:603–7.
Schneider NI, Bauernhofer T, Schöllnast H, Ott A, Langner C. Pancreatic adenocarcinoma with multiple eosinophilic extracellular deposits consistent with noncalcified psammoma bodies. Virchows Arch. 2011;459:623–5.
Further Reading
Halperin DM, Kulke MH. Management of pancreatic neuroendocrine tumors. Gastroenterol Clin North Am. 2012;41:119–31.
Ramage JK, Ahmed A, Ardill J, Bax N, Breen DJ, Caplin ME, et al. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs). Gut. 2012;61:6–32.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag London
About this chapter
Cite this chapter
Campbell, F., Verbeke, C.S. (2013). Endocrine Neoplasia. In: Pathology of the Pancreas. Springer, London. https://doi.org/10.1007/978-1-4471-2449-8_20
Download citation
DOI: https://doi.org/10.1007/978-1-4471-2449-8_20
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-2448-1
Online ISBN: 978-1-4471-2449-8
eBook Packages: MedicineMedicine (R0)